JOYN Advisors’s Integra LifeSciences IART Stock Holding History

JOYN Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-283	Closed	-$13K	–	691
2018 Q4	$13K	Sell	283 -33	-10%	-$1.81K	﹤0.01%	854
2018 Q3	$21K	Buy	316 +4	+1%	+$249	﹤0.01%	669
2018 Q2	$20K	Sell	312 -184	-37%	-$11.4K	﹤0.01%	674
2018 Q1	$27K	Buy	+496	New	+$26K	0.01%	607

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JOYN Advisors's IART Position: Q1 2019 in Review

JOYN Advisors sold out of Integra LifeSciences (IART) in Q1 2019, closing a stake of 283 shares — an estimated $13K sold.

JOYN Advisors first reported a position in IART in Q1 2018 and held it in 4 quarters. The position peaked at $27K in Q1 2018. 259 funds tracked by Wall St. Rank hold IART as of Q1 2019.

JOYN Advisors reported no remaining Integra LifeSciences position as of Q1 2019 after selling out during the quarter.
JOYN Advisors sold 283 Integra LifeSciences shares in Q1 2019, an estimated $13K.
JOYN Advisors first reported a position in Integra LifeSciences in Q1 2018 and held it in 4 quarters.
JOYN Advisors's Integra LifeSciences position peaked at $27K in Q1 2018.
259 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.